N

Nuvalent, Inc.

73 employees

Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2017

Funding rounds raised

Total raised

$135M

from 4 investors over 4 rounds

N

Nuvalent, Inc. raised $135M on May 11, 2021

Investors: Logos Global Management, LP, Driehaus Capital Management LLC, Viking Global Investors and Wellington Management

FAQ